Evidence map›Paper›PMID 32182401›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2020

Salivary Gland Mucosa-Associated Lymphoid Tissue-Type Lymphoma From Sjögren's Syndrome Patients in the Majority Express Rheumatoid Factors Affinity-Selected for IgG.

Richard J Bende, Jerry Janssen, Anna Beentjes, Thera A M Wormhoudt, Koen Wagner, Erlin A Haacke, Frans G M Kroese, Jeroen E J Guikema, Carel J M van Noesel

Open access · hybridAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases.Clinical reviews in allergy & immunology · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Richard J BendeAmsterdam University Medical Center and University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-5173-3138
Jerry JanssenAmsterdam University Medical Center and University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-5855-4119
Anna BeentjesAmsterdam University Medical Center and University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-0195-2823
Thera A M WormhoudtAmsterdam University Medical Center and University of Amsterdam, Amsterdam, The Netherlands.
Koen WagnerAIMM Therapeutics, Amsterdam, The Netherlands.ORCID 0000-0002-5723-8250
Erlin A HaackeUniversity Medical Center Groningen and University of Groningen, Groningen, The Netherlands.
Frans G M KroeseUniversity Medical Center Groningen and University of Groningen, Groningen, The Netherlands.
Jeroen E J GuikemaAmsterdam University Medical Center and University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-6894-3441
Carel J M van NoeselAmsterdam University Medical Center and University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0001-7907-7390
Amsterdam University Medical Centers · NLUniversity Medical Center Groningen · NLAIMM Therapeutics (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePatients with Sjӧgren's syndrome (SS) have an increased risk of developing malignant B cell lymphomas, particularly mucosa-associated lymphoid tissue (MALT)-type lymphomas. We have previously shown that a predominant proportion of patients with SS-associated salivary gland MALT lymphoma express somatically hypermutated IgM with strong amino acid sequence homology with stereotypic rheumatoid factors (RFs). The present study was undertaken in a larger cohort of patients with SS-associated MALT lymphoma to more firmly assess the frequency of RF reactivity and the significance of somatic IGV-region mutations for RF reactivity.

methodsB cell antigen receptors (BCRs) of 16 patients with SS-associated salivary gland MALT lymphoma were analyzed. Soluble recombinant IgM was produced of 12 MALT lymphoma samples, including 1 MALT lymphoma sample that expressed an IgM antibody fitting in a novel IGHV3-30-encoded stereotypic IGHV subset. For 4 of the 12 IgM antibodies from MALT lymphoma samples, the somatically mutated IGHV and IGKV gene sequences were reverted to germline configurations. Their RF activity and binding affinity were determined by enzyme-linked immunosorbent assay and surface plasmon resonance, respectively.

resultsNine (75%) of the 12 IgM antibodies identified in patients with SS-associated salivary gland MALT lymphoma displayed strong monoreactive RF activity. Reversion of the IGHV and IGKV mutations to germline configuration resulted in RF affinities for IgG that were significantly lower for 3 of the 4 somatically mutated IgM antibodies. In stereotypic IGHV3-7/IGKV3-15-encoded RFs, a recurrent replacement mutation in the IGKV3-15-third complementarity-determining region was found to play a pivotal role in the affinity for IgG-Fc.

conclusionA majority of patients with SS-associated salivary gland MALT lymphoma express somatically mutated BCRs that are selected for monoreactive, high-affinity binding of IgG-Fc. These data underscore the notion that soluble IgG, most likely in immune complexes in inflamed tissues, is the principal autoantigen in the pathogenesis of a variety of B cell lymphomas, particularly SS-associated MALT lymphomas.

Indexed as

HumansImmunoglobulin GLymphoma, B-Cell, Marginal ZoneMutationReceptors, Antigen, B-CellRheumatoid FactorSalivary GlandsSjogren's SyndromeImmunoglobulin GReceptors, Antigen, B-CellRheumatoid Factor

Identifiers

PMID32182401
PMCPMC7496822
OpenAlexW3011252093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.